Heron Historical Income Statement
| HRTX Stock | USD 2.95 0.04 1.37% |
Historical analysis of Heron Therapeuti income statement accounts such as Total Revenue of 133.4 M or Gross Profit of 65 M can show how well Heron Therapeuti performed in making a profits. Evaluating Heron Therapeuti income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Heron Therapeuti's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Heron Therapeuti latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Heron Therapeuti is a good buy for the upcoming year.
Heron |
About Heron Income Statement Analysis
Heron Therapeuti Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Heron Therapeuti shareholders. The income statement also shows Heron investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Heron Therapeuti Income Statement Chart
Heron Therapeuti Income Statement is one of the three primary financial statements used for reporting Heron's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Heron Therapeuti revenue and expense. Heron Therapeuti Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Heron Therapeuti's Depreciation And Amortization is fairly stable compared to the past year. Interest Expense is likely to rise to about 4.1 M in 2024, despite the fact that Operating Income is likely to grow to (105.1 M). Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Heron Therapeuti. It is also known as Heron Therapeuti overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Cost Of Revenue
Cost of Revenue is found on Heron Therapeuti income statement and represents the costs associated with goods and services Heron Therapeuti provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Heron Therapeuti's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Heron Therapeuti current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Heron Therapeuti. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.At this time, Heron Therapeuti's Depreciation And Amortization is fairly stable compared to the past year. Interest Expense is likely to rise to about 4.1 M in 2024, despite the fact that Operating Income is likely to grow to (105.1 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 258.2M | 227.5M | 172.6M | 181.2M | Cost Of Revenue | 46.0M | 54.9M | 65.1M | 68.4M |
Heron Therapeuti income statement Correlations
Click cells to compare fundamentals
Heron Therapeuti Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Heron Therapeuti income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 2.0M | 2.8M | 3.0M | 2.9M | 2.9M | 3.0M | |
| Interest Expense | 1.5M | 1.9M | 2.4M | 2.5M | 3.9M | 4.1M | |
| Total Revenue | 146.0M | 88.6M | 86.3M | 107.7M | 127.0M | 133.4M | |
| Gross Profit | 84.3M | 52.4M | 40.3M | 52.8M | 61.9M | 65.0M | |
| Other Operating Expenses | 356.7M | 316.8M | 304.2M | 282.3M | 237.7M | 249.5M | |
| Operating Income | (210.7M) | (228.2M) | (217.8M) | (174.7M) | (110.6M) | (105.1M) | |
| Ebit | (210.7M) | (228.2M) | (217.8M) | (174.7M) | (110.6M) | (105.1M) | |
| Ebitda | (208.7M) | (225.3M) | (214.8M) | (171.8M) | (107.7M) | (102.3M) | |
| Cost Of Revenue | 61.6M | 36.2M | 46.0M | 54.9M | 65.1M | 68.4M | |
| Total Operating Expenses | 295.0M | 280.6M | 258.2M | 227.5M | 172.6M | 181.2M | |
| Income Before Tax | (204.7M) | (227.3M) | (220.7M) | (182.0M) | (110.6M) | (105.0M) | |
| Total Other Income Expense Net | 5.9M | 885K | (2.9M) | (7.4M) | 56K | 53.2K | |
| Net Income | (204.7M) | (224.4M) | (217.7M) | (134.5M) | (110.6M) | (105.0M) | |
| Income Tax Expense | (7.4M) | (2.8M) | (3.0M) | (47.5M) | (42.8M) | (40.6M) | |
| Research Development | 167.4M | 174.5M | 130.8M | 107.5M | 55.9M | 48.9M | |
| Selling General Administrative | 37.9M | 42.2M | 40.2M | 37.4M | 49.0M | 51.5M | |
| Net Income Applicable To Common Shares | (204.7M) | (227.3M) | (220.7M) | (182.0M) | (163.8M) | (172.0M) | |
| Net Income From Continuing Ops | (204.7M) | (227.3M) | (220.7M) | (182.0M) | (119.7M) | (125.7M) | |
| Non Operating Income Net Other | 7.8M | 7.4M | 2.8M | (445K) | (511.8K) | (486.2K) | |
| Net Interest Income | 5.8M | 1.7M | (2.0M) | (836K) | (504K) | (478.8K) | |
| Interest Income | 7.3M | 3.6M | 433K | 1.6M | 3.4M | 2.6M | |
| Selling And Marketing Expenses | 89.8M | 63.9M | 87.2M | 82.5M | 67.6M | 77.0M | |
| Reconciled Depreciation | 2.0M | 2.8M | 3.0M | 2.9M | 3.0M | 2.6M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Heron Therapeuti in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Heron Therapeuti's short interest history, or implied volatility extrapolated from Heron Therapeuti options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Heron Therapeuti. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Heron Stock analysis
When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |
Is Heron Therapeuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Heron Therapeuti. If investors know Heron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Heron Therapeuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.80) | Revenue Per Share 0.92 | Quarterly Revenue Growth 0.14 | Return On Assets (0.25) | Return On Equity (24.09) |
The market value of Heron Therapeuti is measured differently than its book value, which is the value of Heron that is recorded on the company's balance sheet. Investors also form their own opinion of Heron Therapeuti's value that differs from its market value or its book value, called intrinsic value, which is Heron Therapeuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Heron Therapeuti's market value can be influenced by many factors that don't directly affect Heron Therapeuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Heron Therapeuti's value and its price as these two are different measures arrived at by different means. Investors typically determine if Heron Therapeuti is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Heron Therapeuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.